Pain News and Research

Latest Pain News and Research

Children with cancer experiencing extreme pain: 13% of parents consider "hastening death"

A survey of parents who had a child die of cancer found that one in eight considered hastening their child's death, a deliberation influenced by the amount of pain the child experienced during the last month of life, report Dana-Farber Cancer Institute researchers in the March issue of Archives of Pediatrics & Adolescent Medicine.

2 Mar 2010

C1-INH replacement therapy effective for treating acute swelling attacks in HAE

C1-esterase inhibitor (C1-INH) concentrate is an effective, well-tolerated therapy that rapidly relieves acute swelling attacks and successive attacks at any body location in patients with hereditary angioedema (HAE), a rare and serious genetic disorder, according to data presented today at the 2010 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. Additional pharmacokinetic data presented at the meeting confirms that C1-INH concentrate has a longer half-life than other treatment options for HAE, which protects patients from rebound attacks.

2 Mar 2010

Patients with HAE experience prodromal symptoms before acute HAE attacks: Survey

Patients with hereditary angioedema (HAE) experience prodromal or early warning symptoms before nearly three-quarters of their HAE attacks, according to survey findings presented today at the 2010 American Academy of Allergy, Asthma & Immunology Annual Meeting.

2 Mar 2010

Archimedes Pharma raises GBP65 million in new funding

Archimedes Pharma, the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. Archimedes also announced the appointment of a new President and Chief Executive Officer, Jeffrey H. Buchalter, formerly President and Chief Executive Officer of US-based Enzon.

2 Mar 2010

Colonoscopy screening recommended for people with family history of colon cancer

A family history of colon cancer, also known as colorectal cancer or CRC, puts people at higher than average risk for developing the disease.

2 Mar 2010

Balloon Sinuplasty minimally invasive surgery safe for treating chronic sinusitis in children

A recently published study in the American Journal of Rhinology and Allergy demonstrates Balloon Sinuplasty™ technology to be safe when used by physicians in pediatric patients. Known as the INTACT study, this is a prospective, non-randomized, multicenter study and was sponsored by Acclarent, Inc.

2 Mar 2010

Patients admitted to hospice care are rarely having their ICDs deactivated

Researchers from Mount Sinai School of Medicine have found that patients admitted to hospice care who have an implantable cardioverter defibrillator (ICD) are rarely having their ICDs deactivated and are receiving electrical shocks from these devices near the end of life. This first-of-its-kind study of hospice patients with ICDs is published in the March 2, 2010 issue of the Annals of Internal Medicine.

2 Mar 2010

Researchers develop sensitive measuring system for cGVHD

Researchers from The University of Texas M. D. Anderson Cancer Center have developed a new assessment tool to measure the severity of symptoms that can complicate stem cell transplantation. The tool assesses symptoms resulting from chronic graft-versus-host disease (cGVHD), and was presented with supporting research at the 2010 Bone and Marrow Transplant Tandem Meeting.

2 Mar 2010

Stryker Interventional Spine announces the U.S. launch of VertaPlex HV bone cement for VCFs

Stryker Interventional Spine today announced the U.S. launch of VertaPlex® HV. VertaPlex HV is a high viscosity bone cement for use in treating vertebral compression fractures.

From Stryker 2 Mar 2010

Study shows high rate of shoulder dislocation in young males and elderly women

An article published in the March 2010 issue of The Journal of Bone and Joint Surgery reveals that the majority of all shoulder dislocations occur during sports activities and young males are at a higher risk. The study also shows a high rate of shoulder dislocation in elderly women.

2 Mar 2010

Palliative care helps improve quality, cut end of life care costs

The Philadelphia Inquirer reports on palliative care and focuses on a fairly typical American hospital in Abington.

1 Mar 2010

Breastfeeding and better hygiene may protect against peptic ulcer bacterium infection

Young children in developing countries are infected at an early age with the bacterium Helicobacter pylori, which can cause peptic ulcers and stomach cancer. New findings show that childrens´ immune responses help in fighting the bacteria. In addition, breastfeeding and better hygiene appear to protect against infection. The results provide hope for a vaccine, according to research from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

1 Mar 2010

Outpatient referrals from primary care physicians for CT, MRI studies inappropriate: Academic medical center

A large academic medical center has found that a significant percentage of outpatient referrals they receive from primary care physicians for computed tomography (CT) and magnetic resonance imaging (MRI) studies are inappropriate (based upon evidence-based appropriateness criteria developed by a radiology benefits management company), according to a study in the March issue of the Journal of the American College of Radiology (www.jacr.org).

1 Mar 2010

BDSI provides update on product portfolio, key upcoming milestones

BioDelivery Sciences International, Inc. today provided a summary of its business overview webcast that was conducted on Thursday, February 25, 2010. Dr. Mark A. Sirgo, President and Chief Executive Officer, and Dr. Andrew L. Finn, Executive Vice President of Product Development, provided an update on the product portfolio, including development plans, anticipated timelines, and key upcoming milestones.

28 Feb 2010

Republicans press campaign against reconciliation; Mccain seek to strip Medicare out of health bill

Republicans and Democrat hit the Sunday talk shows today to debate whether a complex congressional process called 'reconciliation' should be used to consider a major overhaul of the U.S. health care system. Reconciliation is normally used for 'taxing and spending and reducing deficits,' said Sen.

28 Feb 2010

Bioethics expert: Parents should be allowed to use selective reproduction in choosing future child's gender

A bioethics expert has argued that parents should be allowed to use selective reproduction to choose their future child's gender and to screen out serious disease and disability.

27 Feb 2010

Prevention of recurrent strokes: Antiplatelet drug cilostazol effective and safer than aspirin

The antiplatelet drug cilostazol — used in the United States to treat leg pain associated with peripheral vascular disease — was more effective and safer than aspirin at preventing recurrent strokes in a Japanese trial presented as late-breaking science at the American Stroke Association's International Stroke Conference 2010.

27 Feb 2010

Criticism, passion emerge at health care summit

NPR interviewed Rep. Dave Camp, ranking Republican on the House Ways and Means Committee. Camp said: "We were able to at least be heard and have some exposure to the ideas that we've been promoting for a long time. And the president did finally say in the close that we do have ideas that lower costs in insurance and that — do it without increasing taxes. And we don't cut Medicare. And we don't have new mandates in our proposals. So this is really the first opportunity we've had to really focus not only our colleagues and the president, but also the American people on the proposals we've had" (Siegel, 2/25).

26 Feb 2010

Gaucher disease: FDA approves VPRIV

The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease.

26 Feb 2010

Wound Management Technologies announces recent increase in sales of CellerateRx throughout U.S.

Wound Management Technologies, Inc. announced today that the recent increase in sales activities throughout the United States has resulted in 45 new clinicians evaluating their advanced wound care collagen product, CellerateRx® . In the last two months, these evaluations have transpired into new customers in Arizona, New Mexico, South Carolina, North Dakota, New Jersey, Wyoming, Colorado, and New York.

26 Feb 2010

Pain News and Research

Latest Pain News and Research

Children with cancer experiencing extreme pain: 13% of parents consider "hastening death"

C1-INH replacement therapy effective for treating acute swelling attacks in HAE

Patients with HAE experience prodromal symptoms before acute HAE attacks: Survey

Archimedes Pharma raises GBP65 million in new funding

Colonoscopy screening recommended for people with family history of colon cancer

Balloon Sinuplasty minimally invasive surgery safe for treating chronic sinusitis in children

Patients admitted to hospice care are rarely having their ICDs deactivated

Researchers develop sensitive measuring system for cGVHD

Stryker Interventional Spine announces the U.S. launch of VertaPlex HV bone cement for VCFs

Study shows high rate of shoulder dislocation in young males and elderly women

Palliative care helps improve quality, cut end of life care costs

Breastfeeding and better hygiene may protect against peptic ulcer bacterium infection

Outpatient referrals from primary care physicians for CT, MRI studies inappropriate: Academic medical center

BDSI provides update on product portfolio, key upcoming milestones

Republicans press campaign against reconciliation; Mccain seek to strip Medicare out of health bill

Bioethics expert: Parents should be allowed to use selective reproduction in choosing future child's gender

Prevention of recurrent strokes: Antiplatelet drug cilostazol effective and safer than aspirin

Criticism, passion emerge at health care summit

Gaucher disease: FDA approves VPRIV

Wound Management Technologies announces recent increase in sales of CellerateRx throughout U.S.

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Pain News and Research

Latest Pain News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in